Literature DB >> 16554023

The C-terminal 26-residue peptide of serpin A1 is an inhibitor of HIV-1.

Luis Fernando Congote1.   

Abstract

Serpin A1 (alpha1-proteinase inhibitor) inhibits human immunodeficiency virus 1 (HIV-1) production by mechanisms which remain to be elucidated. The complex formation of serpin A1 with proteinases eliminates the proteolytic activity and generates a fragment corresponding to the serpin C-terminal 36-residue peptide. Here, we show that the C-terminal 26-residue peptide of serpin A1 (A1-C26) inhibits HIV-long terminal repeat (LTR)-driven transcription in epithelial cells transfected with HIV-1 LTR promoter-driven genes. A1-C26 increased STAT1 phosphorylation and strongly reduced viral expression in a monocytic cell line infected with HIV-1 NL4-3. This reduction of expression was also observed in HIV-1 infected, PHA-activated peripheral blood mononuclear cells. In HIV-1 infected cells, the inhibitory activity of HIV-1 caused by B9-C23 and C1-C26, the A1-C26 homologues corresponding to the C-terminal sections of serpin B9 and serpin C1, was much lower than that obtained with A1-C26. These serpin peptides represent a novel class of antiviral agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16554023     DOI: 10.1016/j.bbrc.2006.02.190

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

1.  Plasma proteomic analysis of simian immunodeficiency virus infection of rhesus macaques.

Authors:  Jayme L Wiederin; Robert M Donahoe; James R Anderson; Fang Yu; Howard S Fox; Howard E Gendelman; Pawel S Ciborowski
Journal:  J Proteome Res       Date:  2010-09-03       Impact factor: 4.466

Review 2.  Systems biology-based approaches to understand HIV-exposed uninfected women.

Authors:  Adam Burgener; J Sainsbury; F A Plummer; T Blake Ball
Journal:  Curr HIV/AIDS Rep       Date:  2010-05       Impact factor: 5.071

3.  Reactive Center Loop (RCL) Peptides Derived from Serpins Display Independent Coagulation and Immune Modulating Activities.

Authors:  Sriram Ambadapadi; Ganesh Munuswamy-Ramanujam; Donghang Zheng; Colin Sullivan; Erbin Dai; Sufi Morshed; Baron McFadden; Emily Feldman; Melissa Pinard; Robert McKenna; Scott Tibbetts; Alexandra Lucas
Journal:  J Biol Chem       Date:  2015-11-30       Impact factor: 5.157

4.  HIV replication in CD4+ T lymphocytes in the presence and absence of follicular dendritic cells: inhibition of replication mediated by α-1-antitrypsin through altered IκBα ubiquitination.

Authors:  Xueyuan Zhou; Leland Shapiro; Gilbert Fellingham; Barry M Willardson; Gregory F Burton
Journal:  J Immunol       Date:  2011-01-24       Impact factor: 5.422

Review 5.  Expanding the clinical indications for α(1)-antitrypsin therapy.

Authors:  Eli C Lewis
Journal:  Mol Med       Date:  2012-09-07       Impact factor: 6.354

6.  α₁-Antitrypsin modulates lung endothelial cell inflammatory responses to TNF-α.

Authors:  Angelia D Lockett; Samuel Kimani; Godfrey Ddungu; Sabine Wrenger; Rubin M Tuder; Sabina M Janciauskiene; Irina Petrache
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

7.  Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infection.

Authors:  Holger B Kramer; Kerry J Lavender; Li Qin; Andrea R Stacey; Michael K P Liu; Katalin di Gleria; Alison Simmons; Nancy Gasper-Smith; Barton F Haynes; Andrew J McMichael; Persephone Borrow; Benedikt M Kessler
Journal:  PLoS Pathog       Date:  2010-05-06       Impact factor: 6.823

8.  Monocyte CD49e and 110-120 kDa fibronectin fragments: HIV prognostic indicators independent of viral load and CD4 T-cell counts.

Authors:  Roger D Rossen; Jose A Rubio; Wendy J Porter; JoAnn Trial; Frank M Orson; Maria C Rodriguez-Barradas; Holly H Birdsall
Journal:  AIDS       Date:  2009-11-13       Impact factor: 4.177

9.  Influenza Virus H1N1 inhibition by serine protease inhibitor (serpin) antithrombin III.

Authors:  Donald F Smee; Brett L Hurst; Craig W Day; Ralf Geiben-Lynn
Journal:  Int Trends Immun       Date:  2014-04-01

10.  Alpha1-antitrypsin inhibits the activity of the matriptase catalytic domain in vitro.

Authors:  Sabina Janciauskiene; Izabela Nita; Devipriya Subramaniyam; Qian Li; Jack R Lancaster; Sadis Matalon
Journal:  Am J Respir Cell Mol Biol       Date:  2008-08-21       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.